CYP2D6 and Plasmodium vivax malaria: The current study further analysed CYP2D6 genotype and its predicted enzyme activity in vivax malaria patients from Yunnan Province population who underwent PQ treatment in order to systematically understand factors that may adversely affect deployment of PQ for radical cure of vivax malaria in Yunnan Province.